Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis

Digestive Diseases and Sciences

Volumn 44, Issue 12, 1999, Pages 2439-2442

  Bortolotti, Mauro ^a   Mari, C ^a   Brunelli, F ^a   Sarti, P ^a   Miglioli, M ^a  

^a NONE

Author keywords

Clarithromycin; Gastrointestinal motility; Helicobacter pylori; Manometry; Migrating motor complex; Prokinetic drugs; Stomach

Indexed keywords

CLARITHROMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; FEMALE; GASTRITIS; GASTROINTESTINAL MOTILITY; HELICOBACTER PYLORI; HUMAN; MALE; MANOMETRY; MIGRATING MYOELECTRIC COMPLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033401620     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026674719476     Document Type: Article

References (18)

1. 1. Bortolotti M, Brunelli F, Sarti, Romor A, Miglioli M: Effects of clarithromycin and amoxicillin on interdigestive gastrointestinal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. Neurogastroenterol Motil 10:61, 1998
2. 2. Schwanz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J: Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer occurrence: A randomized, double blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 93:584-590, 1998
3. 3. Lindsetmo RO, Johnsen R, Revhaugh A: Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagolomized patients with dyspeptic complaints. A randomized, double blind, placebo controlled, clinical study without pretreatment diagnostic upper endoscopy. Scand J Gastroenterol 33:231-235, 1998
4. 4. Annese V, Janssens J, Vantrappen G, Tack J, Peeters TL, Willemse P, Van Cutsem E: Erythromycin accelerates gastric emptying by inducing antral contractions und improved gastroduodenal coordination. Gastroenterology 102:823-828, 1992
5. 5. Tomomasa T, Kuroume T, Arai H, Wakabayashi K, Itoh Z: Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 31:157-161, 1986
6. 6. Peeters TL: Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105:1886-1899, 1993
7. 7. Bjornsson ES, Abrahamsson H: Comparison between physiologic and erytromycin-induced interdigestive motility. Scand J Gastroenterol 30:139-145, 1995
8. 8. Sarna S, Soergel K, Koch T, Stone JE, Wood CM, Ryan RP, Arndorfer RC, Cavanaugh JH, Nellans HN, Lee MB: Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 101:1488-1496, 1991
9. 9. Talley NJ, Colin DG, Koch KL, Koch M, Nyrén O, Stanghellini V: Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 4:145-160, 1991
10. 10. Peeters TL, Mattijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G: Erythomycin and its derivatives are motilin receptor agonists. Biomed Res Suppl 1:95, 1988
11. 11. Mitty RD, Hechavarria E, Murthi D, Cave DR: Treatment of non-ulcer dyspepsia associated with Helicobacter pylori with omeprazole + clarithromycin: A placebo-controlled, doubleblind study. Gastroenterology 112:A221, 1997
12. 12. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain J, De Roomuls E, Bouillon R: Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 322:1028-1031. 1990
13. 13. Richards RD, Davenport K. McCallum RW: The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral crythromycin. Am J Gastroenterol 88:203-207. 1993
14. 14. Chami TN, Schuster MM, Crowell MD, Whitehead WE: Effects of low dose erythromycin on gastrointestinal motility and symptoms in chronic intestinal pseudo-obstruction. Gastroenterology 100:A41, 1991
15. 15. Di Lorenzo C, Flores AF, Tomomasa T, Hyman PE: Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms. Dig Dis Sci 39:1399-1404, 1994
16. 16. Cucchiara S, Minella R, Scoppa A, Emiliano M, Calabrese F, Az-Zeqeh N, Rea B, Salvia G: Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. J Pediatr Gastroenterol Nutr 24:411-418, 1997
17. 17. Nellans HN, Peeters TL. Petersen AC: Stimulation of gastrointestinal motility: Clarithromycin less potent than azithromycin. In Proceedings of the 17th International Congress of Chemotherapy. Berlin 1991. pp 2286-2287
18. 18. Depoortere I, Peeters TL., Mattijs G, Cachet T. Hoogmartnes J, Vantrappen G: Structure-activity relation of erythromycin-related macrolides in inducing contractions and in displacing bound motilin in rabbit duodenum. J Gastrointest Motil 1:150-159. 1989